If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt Diag Hld Regulatory News (IDHC)

Share Price Information for Int Diag Hld (IDHC)

Share Price is delayed by 15 minutes
Get Live Data
0.51    0.008 (1.59%)
Bid:
0.51
Ask:
0.516
Spread: 0.006 (1.176%)
Market Cap: $296.48m
IDHC Live PriceLast checked at - London Stock Exchange

Intraday Int Diag Hld Share Chart

Directorate Change

1 Mar 2022 14:00

RNS Number : 2260D
Integrated Diagnostics Holdings PLC
01 March 2022
 

Integrated Diagnostics Holdings PLC

1 March 2022

 

 

Integrated Diagnostic Holdings plc (the "Company")

 

Directorate Change

 

 

The Board announces the appointment of Ms Yvonne Stillhart, as a Non-Executive Director of the Company with effect from 1 March 2022. Yvonne also joins the Audit and the Remuneration Committees.

Yvonne is a seasoned Senior Executive working with innovation and growth driven companies across a wide range of industries and geographical regions, including Europe, USA, North Africa and Sub-Sahara Africa. She has been a Non-Executive Director and Audit and Risk Committee Member for more than 12 years. She has co-founded and led as a Senior Partner a specialised private equity manager in Switzerland. For several decades Yvonne has been a senior executive leader in international businesses, private market and infrastructure investments. She is focussed on business building and transformation, risk management and ESG governance.

 

Yvonne serves currently as a non-executive Director of UBS Asset Management Switzerland Ltd. and is the Chairperson of the South African EPE Capital Ltd. She is also on the Board of Standard Life Private Equity Trust Plc.

 

Yvonne holds a Director Certificate from Harvard Business School, the Corporate Risk Certificate from the DCRO Institute and the ESG Competent Boards Certificate.

 

Yvonne replaces James Nolan who resigned on 1 September 2021.

 

There are no other details that are required to be disclosed under the Financial Conduct Authority LR 9.6.13 of the Listing Rules in relation to this appointment.

 

 

 

 

 

For further information please contact:

 

Integrated Diagnostic Holdings plc

 

+20(0)2 3345 5530

Nancy Fahmy

Investor Relations Director

 

Company Secretary:

Link Company Matters Limited

IDHLondon@linkgroup.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUBPWUPPGWG
Date   Source Headline
6th Jul 20264:39 pmRNSForm 8.3 - Integrated Diagnostics Holdings PLC
6th Jul 20261:13 pmRNSForm 8.3 - INTEGRATED DIAGNOSTICS HLDGS PLC
3rd Jul 202612:47 pmRNSForm 8 - Integrated Diagnostics Holdings Plc
3rd Jul 20267:00 amRNSForm 8.3 - Integrated Diagnostics Holdings PLC
2nd Jul 20263:25 pmRNSForm 8.3 - INTEGRATED DIAGNOSTICS HOLDINGS PLC
1st Jul 20264:44 pmRNSForm 8.3 - Integrated Diagnostics Holdings PLC
1st Jul 20263:17 pmRNSForm 8.3 - INTEGRATED DIAGNOSTICS HOLDINGS PLC
1st Jul 202610:56 amRNSOPD Rule 8.3 – Integrated Diagnostics Holdings plc
1st Jul 20267:00 amRNSForm 8.3 - Integrated Diagnostics Holdings Replace
1st Jul 20267:00 amRNSForm 8.3 - Integrated Diagnostics Holdings Replace
30th Jun 20264:20 pmRNSForm 8.3 - Integrated Diagnostics Holdings PLC
30th Jun 20267:00 amRNSForm 8.3 - Integrated Diagnostics Holdings PLC
29th Jun 202610:12 amRNSForm 8.3 - Integrated Diagnostics Holdings PLC
26th Jun 20265:06 pmRNSForm 8.3 - Integrated Diagnostics Holdings PLC
26th Jun 20265:04 pmRNSForm 8.3 - Integrated Diagnostics Holdings PLC
26th Jun 20264:59 pmRNSForm 8.3 - Integrated Diagnostics Holdings PLC
25th Jun 20262:47 pmRNSForm 8.3 Integrated Diagnostics Holdings Plc
25th Jun 20267:00 amPRNForm 8.3 - Integrated Diagnostics Holdings plc
24th Jun 20263:37 pmRNSHolding(s) in Company
24th Jun 20263:19 pmRNSForm 8.3 - INTEGRATED DIAGNOSTICS HOLDINGS PLC
24th Jun 20262:30 pmRNSForm 8 (OPD) - IDH plc - Hena Holdings Ltd
24th Jun 202610:44 amRNSForm 8.3 - Integrated Diagnostic Holdings plc
24th Jun 20269:26 amPRNForm 8.3 - Integrated Diagnostics Holdings plc
23rd Jun 20265:05 pmRNSDirector/PDMR Shareholding
23rd Jun 20265:03 pmRNSHolding(s) in Company
23rd Jun 20263:53 pmRNSStatement re Mandatory Final Cash Offer
23rd Jun 202610:41 amRNSDisclosure Table
23rd Jun 202610:15 amRNSMANDATORY FINAL CASH OFFER
20th May 20262:05 pmRNSReplacement - 1st Quarter Results
20th May 20267:00 amRNS1st Quarter Results
19th May 20265:09 pmRNSResult of AGM
30th Apr 202612:39 pmRNSReplacement - Holding(s) in Company
23rd Apr 20261:06 pmRNSAnnual Financial Report & Notice of AGM
17th Apr 20267:00 amRNSFinal Results
8th Apr 20265:50 pmRNSHolding(s) in Company
8th Apr 20265:49 pmRNSHolding(s) in Company
13th Nov 20257:00 amRNS3rd Quarter Results
7th Nov 20257:00 amRNSNotice of Results
2nd Sep 20257:00 amRNSHalf-year Report
29th Aug 202511:55 amRNSNotice of Results
20th Jun 20257:00 amRNSIDH Strengthens Egyptian Radiology portfolio
28th May 20257:00 amRNS1st Quarter Results
27th May 20255:00 pmRNSResult of AGM
22nd May 20257:00 amRNSNotice of Results
24th Apr 20253:30 pmRNSAnnual Financial Report & Notice of AGM
17th Apr 20257:00 amRNSFinal Results
10th Apr 20254:41 pmRNSNotice of Results
9th Dec 202410:59 amRNSIDH INCREASES STAKE IN BIOLAB KSA
14th Nov 20247:00 amRNS3rd Quarter Results
11th Nov 202411:29 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.